Leerink Partners analyst Mani Foroohar has maintained their bullish stance on TNYA stock, giving a Buy rating yesterday.Stay Ahead of the ...

Powered by AliveCor's proprietary KAI 12L AI technology, the pocket-sized Kardia 12L ECG System was designed exclusively for ...

For children with severe hypertrophic cardiomyopathy caused by gain-of-function RAS/mitogen-activated protein kinase ( ...

PDUFA Target Action Date for Aficamten Set for September 26, 2025;Commercial Launch Preparations Underway for First Potential ApprovalFive-Year ...

Background and aims Hypertrophic cardiomyopathy (HCM) has various aetiologies, including genetic conditions like Fabry ...

A study reveals that a personalized approach, considering age, sex and size, improves the diagnosis of hypertrophic ...

Women may be missing a diagnosis of a potentially deadly heart condition due to guidelines that don't account for natural differences in sex and body size.

Women may be missing a diagnosis of a potentially deadly heart condition due to guidelines that don't account for natural differences in sex and body size, according to a new study led by UCL ...

After the successful development of mavacamten and the sale of MyoKardia to BMS in 2020, former executives of the biotech are ...

A man tragically died eight months after he defied the odds to survive a cardiac arrest. Matt Clare's loved ones were told ...

Dr. Lakshmi Sundar emphasizes the importance of exercise for health while addressing the risk of sudden cardiac death in ...

Trametinib, a mitogen-activated protein kinase (MEK) inhibitor, reduces mortality and morbidity in children with severe ...